Review Flashcards
CNI
TACROLIMUS
CYCLOSPORINE
ANTIPROLIFERATIVE AGENTS/ANTIMETABOLITES
AZATHIOPRINE
MYCOPHENOLATE MOFETIL
MYCOPHENOLATE SODIUM
MTOR INHIBITORS
SIROLIMUS
EVEROLIMUS
ANTIBODIES
ATGAM THYMOGLOBULIN BASILIXIMAB RITUXIMAB ATEMTUXUMAB IVIG
PROTEASOME INHIBITOR
BORTEZOMIB
POLYCLONAL ANTIBODIES MOA
T-CELL DEPLETION
CYTOTOXIC ACTIVITIES
MODULATION OF T CELL ACTIVATION
POLYCLONAL ANTIBODIES ADVERSE REACTIONS
CYTOKINE RELEASE SYNDROME LEUKOPENIA/THROMBOCYTOPENIA SERUM SICKNESS ANAPHYLAXIS INFECTION MALIGNANCIES-PTLD
POLYCLONAL ADVANTAGES
STRONGER, CAN BE USED TO TREAT REJECTION
POLYCLONAL DISADVANTAGES
ACUTE SIDE EFFETS
HIGHER INFECTION RATES
HIGHER MALIGNANCY RATES
MONOCLONAL ADVANTAGES
NO ACUTE SIDE EFFECTS
NOT ASSOCIATED WITH HIGH INFECTION OR MALIGNANCY RATES
MONOCLONAL DISADVANTAGES
WEAKER, CANNOT BE USED TO TREAT REJECTION
TACROLIMUS DOSING
0.1-0.15 MG/KG/DAY PO DIVIDED BID
CYCLOSPORINE MOA
INHIBITS FIRST PHASE OF T CELL ACTIVATION
REDUCES LEVEL OF CIRCULATING T CELLS
CYCLOSPORINE DOSING
5-10 MG/KG/DAY DIVIDED BID
CNI NEPHROTOXICITY
TAC=CYCLO
CNI HYPETENSION
CYCLO>TAC
CNI DM
TAC>CYCLO
CNI NEUROTOXICITY
TAC>CYCLO
CNI COSMETIC EFFECTS
CYCLO>TAC
CNI GI EFFECTS
TAC>CYCLO
CNI HYPERKALEMIA
TAC>CYCLO
CNI HLD
CYCLO>TAC
CNI LOW MAG
CYCLO=TAC
THINGS THAT INCREASE CNI LEVELS
- ZOLES
- MYCINS
- GRAPEFRUIT/POMEGRANATE JUICE
- DILT, VERAPAMIL, AMIO
- FLUOXETINE
- PROTEASE INHIBITORS
- REGLAN
- SIMEPRAVIR